SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thai Chung who wrote (1717)3/6/2000 11:22:00 PM
From: yosid  Read Replies (1) of 1754
 
VISX will fight on two fronts now.
They will gear-up to maintain and/or expand on the 70% market share. They will buy back stock, cut cost, and more importantly, I think they will merge with a newer technology to compete with newcomers. Machine sales will not sustain any of the laser manufacturers, so royalties, service revenue, ect. will be in their favor for the next several quarters.
If the patent office rules in their favor (PTO), look for VISX to put some big bucks on the table to sue, collect royalties, and get injunctions against many of the producers and users of lasers in the USA. I think such a turn of events would bring VISX back to a growth company status (new economy)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext